130 related articles for article (PubMed ID: 22146408)
21. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
22. GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study.
Zupa A; Sgambato A; Bianchino G; Improta G; Grieco V; LA Torre G; Campisi B; Traficante A; Aieta M; Cittadini A
Anticancer Res; 2009 May; 29(5):1709-14. PubMed ID: 19443391
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia.
Krajinovic M; Richer C; Sinnett H; Labuda D; Sinnett D
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):557-62. PubMed ID: 10868688
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis].
Ivashchenko TE; Shved NIu; Kramareva NA; Aĭlamazian EK; Baranov VS
Genetika; 2003 Apr; 39(4):525-9. PubMed ID: 12760253
[TBL] [Abstract][Full Text] [Related]
25. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
[TBL] [Abstract][Full Text] [Related]
26. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms of xenobiotic-metabolizing enzymes influence the risk of pulmonary emphysema.
Kukkonen MK; Hämäläinen S; Kaleva S; Vehmas T; Huuskonen MS; Oksa P; Vainio H; Piirilä P; Hirvonen A
Pharmacogenet Genomics; 2011 Dec; 21(12):876-83. PubMed ID: 22027651
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
Kim WJ; Lee HL; Lee SC; Kim YT; Kim H
J Urol; 2000 Jul; 164(1):209-13. PubMed ID: 10840461
[TBL] [Abstract][Full Text] [Related]
29. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands).
van der Hel OL; Bueno-de-Mesquita HB; van Gils CH; Roest M; Slothouber B; Grobbee DE; Peeters PH
Cancer Causes Control; 2005 Aug; 16(6):675-81. PubMed ID: 16049806
[TBL] [Abstract][Full Text] [Related]
30. [Polymorphisms of RAD51(G135C) and XRCC3(C241T) genes and correlations thereof with prognosis and clinical outcomes of acute myeloid leukemia].
Liu L; Yang L; Zhang Y; Xu ZF; Yu MH; Wang JX; Xiao ZJ
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):378-82. PubMed ID: 18581889
[TBL] [Abstract][Full Text] [Related]
31. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
[TBL] [Abstract][Full Text] [Related]
32. Distribution of xenobiotic metabolising enzyme genotypes in different Tunisian populations.
Ouerhani S; Ben Bahria I; Rouissi K; Cherni L
Ann Hum Biol; 2017 Jun; 44(4):366-372. PubMed ID: 27978766
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
[TBL] [Abstract][Full Text] [Related]
34. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
35. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogenetics.
Lee HS; Lee JH; Hur EH; Lee MJ; Lee JH; Kim DY; Kim SH; Seol M; Kang SI; Ryu SG; Kang YA; Lee YS; Kang MJ; Seo EJ; Kim YS; Chi HS; Park CJ; Jang S; Yun SC; Lee KH
Leuk Res; 2009 Mar; 33(3):426-33. PubMed ID: 18760837
[TBL] [Abstract][Full Text] [Related]
38. [Genetic polymorphism of gluthation-S transferases and N-acetyl transferases 2 and nasopharyngeal carcinoma: the Tunisia experience].
Bendjemana K; Abdennebi M; Gara S; Jmal A; Ghanem A; Touati S; Boussen H; Ladgham A; Guemira F
Bull Cancer; 2006 Mar; 93(3):297-302. PubMed ID: 16567317
[TBL] [Abstract][Full Text] [Related]
39. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG
Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218
[TBL] [Abstract][Full Text] [Related]
40. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes.
Skjelbred CF; Svendsen M; Haugan V; Eek AK; Clausen KO; Kure EH; Tuimala JT; Svendsen MV; Norppa H; Hansteen IL
Carcinogenesis; 2011 Mar; 32(3):399-405. PubMed ID: 21097530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]